EyeCon 2025: The latest on treating ocular surface and cornea disease | Optometry Times - Clinical News

Published on September 26, 2025
Continue reading on website
Other news

US FDA authorizes marketing of Essilor Stellest eyeglass lenses for the correction of myopia | Optometry Times - Clinical News

September 26, 2025
The lens works to slow the progression of myopia in children aged 6-12 at the initiation of treatment.

EyeCon 2025: Expanding options for ocular surface disease with Joseph Allen, OD, FAAO, Dipl ABO | Optometry Times - Clinical News

September 26, 2025